跳至主要内容
临床试验/NCT05892705
NCT05892705已完成4 期

Can Subarachnoid Dexmedetomidine Decrease the Incidence of Postoperative Nausea and Vomiting and Shivering With Minimal Hemodynamic Instability in CS?

Ain Shams University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Effect of subarachnoid dexmedetomidine on hemodynamic parameters.

研究概览

简要总结

Background: Highly selective α-2 agonist dexmedetomidine in increasingly used as an intrathecal adjuvant for caesarean section performed under subarachnoid block.

Aim of the Study: The aim of the study is to determine whether low dose dexmedetomidine added to local anesthetic for spinal anesthesia will attenuate perioperative nausea and vomiting and shivering in lower segment caesarean section (LSCS) with minimal hemodynamic instability or not.

Patients and Methods: Sixty parturients planned for elective CSs under spinal anesthesia were enrolled in this prospective controlled study and randomly divided into two equal groups. Spinal block was achieved with 10mg hyperbaric bupivacaine 0.5% plus 5µg dexmedetomidine (group D) (dexmedetomidine group) or 0.2 ml normal saline (group C) (control group). Hemodynamic parameters, incidence of nausea and vomiting and shivering were recorded.

Keywords: Dexmedetomidine, Cesarean Section, Bupivacaine, Spinal Anesthesia, Shivering, PONV

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Medically free pregnant Female from 18 to 30 yrs old.
  • Undergoing elective LSCS.
  • Body mass index less than
  • Consenting for sub arachnoid anesthesia.
  • Coagulation profile is within normal ranges.

排除标准

  • Emergency LSCS.
  • Patient refusal enrollment in the study.
  • Allergy to the medications.
  • Coagulopathy or anticoagulation drugs.
  • Fetal or Maternal comorbidities.

研究组 & 干预措施

Study drug (dexmedetomidine intrathecal)

Active Comparator

5 mcg dexmedetomidine intrathecally injected with 10 mg hyperbaric bupivacaine during spinal anesthesia for caesarean section.

干预措施: Dexmedetomidine Injection [Precedex] (Drug)

Control (saline)

Placebo Comparator

0.2 ml normal saline intrathecally injected with 10 mg hyperbaric bupivacaine during spinal anesthesia for caesarean section.

干预措施: Dexmedetomidine Injection [Precedex] (Drug)

结局指标

主要结局

Effect of subarachnoid dexmedetomidine on hemodynamic parameters.

时间窗: Two hours

Measure heart rate, blood pressure, temperature, oxygen saturation

次要结局

  • Effect of subarachnoid dexmedetomidine on incidence of postoperative nausea and vomiting (PONV) and shivering.(Six hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shaimaa Mohamed Samir Ezzat Rakhia

MD

Ain Shams University

研究点 (1)

Loading locations...

相似试验